Neogenomics (NEO) Income from Continuing Operations (2010 - 2026)
Neogenomics (NEO) posted Income from Continuing Operations of 17106000.0 for Q1 2026, down 73.12% quarter-over-quarter from 9881000.0 in Q4 2025, and up 34.01% year-on-year from 12764503.11 in Q1 2025.
Neogenomics (NEO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Income from Continuing Operations for 17 consecutive years, with 17106000.0 the latest figure, recorded in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 17106000.0, up 34.01% year-over-year; the trailing twelve-month figure through Mar 2026 was 99208000.0 (down 27.87% YoY), and the FY2025 annual result was 108025000.0, down 37.22% from the prior year.
- Income from Continuing Operations was 17106000.0 for Q1 2026 at Neogenomics, down from 9881000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 9881000.0 in Q4 2025 and troughed at 49408000.0 in Q1 2022.
- Average Income from Continuing Operations over 5 years is 25651470.59, with a median of 24331000.0 recorded in 2023.
- Year-over-year, Income from Continuing Operations sank 146.53% in 2022 and surged 49.76% in 2023.
- Over 5 years, Income from Continuing Operations stood at 22687000.0 in 2022, then jumped by 36.85% to 14326000.0 in 2023, then declined by 6.97% to 15324000.0 in 2024, then soared by 35.52% to 9881000.0 in 2025, then plunged by 73.12% to 17106000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 17106000.0 in Q1 2026, 9881000.0 in Q4 2025, and 27129000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -17.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.11 Mn |
| Dec 31, 2025 | -9.88 Mn |
| Sep 30, 2025 | -27.13 Mn |
| Jun 30, 2025 | -45.09 Mn |
| Mar 31, 2025 | -25.92 Mn |
| Dec 31, 2024 | -15.32 Mn |
| Sep 30, 2024 | -17.70 Mn |
| Jun 30, 2024 | -18.64 Mn |
| Mar 31, 2024 | -27.06 Mn |
| Dec 31, 2023 | -14.33 Mn |
| Sep 30, 2023 | -18.52 Mn |
| Jun 30, 2023 | -24.33 Mn |
| Mar 31, 2023 | -30.80 Mn |
| Dec 31, 2022 | -22.69 Mn |
| Sep 30, 2022 | -36.85 Mn |
| Jun 30, 2022 | -35.30 Mn |
| Mar 31, 2022 | -49.41 Mn |
| Dec 31, 2021 | -41.76 Mn |
| Sep 30, 2021 | -20.35 Mn |
| Jun 30, 2021 | 75.87 Mn |